Kent Lake PR’s Bioventus BVS Stock Holding History

Kent Lake PR’s Portfolio BVS Stock Details BVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	$6.69M	Buy	1,000,200 +650,164	+186%	+$4.51M	3.38%	12
2025 Q2	$2.32M	Buy	+350,036	New	+$2.48M	1.02%	33

Other funds holding BVS

EWM

Essex Woodlands Management The Woodlands, Texas $254M AUM 4.59% 1-Year Est. Return

JIC

Juniper Investment Company New York $378M AUM 95.37% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Kent Lake PR's BVS Position: Q3 2025 in Review

Kent Lake PR increased its Bioventus (BVS) stake by 186% in Q3 2025, buying an estimated $4.51M and bringing the position to 1,000,200 shares worth $6.69M. The position accounts for 3.38% of the portfolio, ranked #12.

Kent Lake PR first reported a position in BVS in Q2 2025 and has held it in 2 quarters since. 135 funds tracked by Wall St. Rank hold BVS as of Q3 2025.

Kent Lake PR held 1,000,200 shares of Bioventus worth $6.69M as of Q3 2025.
Kent Lake PR bought 650,164 Bioventus shares in Q3 2025, an estimated $4.51M.
Bioventus made up 3.38% of Kent Lake PR's portfolio in Q3 2025, its #12 holding.
Kent Lake PR first reported a position in Bioventus in Q2 2025 and has held it in 2 quarters since.
135 funds tracked by Wall St. Rank held Bioventus as of Q3 2025.

Based on Kent Lake PR's 13F filing for Q3 2025, filed 14 Nov 2025.